The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population

The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population

Severe respiratory syncytial virus (RSV) bronchiolitis in early life is a significant risk factor for future recurrent wheeze (RW) and asthma. The goal of the Azithromycin to Prevent Wheezing following severe RSV bronchiolitis II (APW-RSV II) clinical trial is to evaluate if azithromycin treatment i...

Full description

Bibliographic Details
Main Authors: Mythili Srinivasan, Leonard B. Bacharier, Charles W. Goss, Yanjiao Zhou, Jonathan Boomer, Sarah Bram, Dana Burgdorf, Carey-Ann Burnham, Timothy Casper, Mario Castro, Andrea Coverstone, Matthew Haslam, Watcharoot Kanchongkittiphon, Cadence Kuklinski, Qinghua Lian, Kenneth Schechtman, Gregory A. Storch, Kelly True, Meghan A. Wallace, Huiqing Yin-DeClue, Elizabeth Ahrens, Jinli Wang, Avraham Beigelman
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Contemporary Clinical Trials Communications
Subjects:
Respiratory syncytial virus (RSV) bronchiolitis
Azithromycin
Recurrent wheezing
Asthma
Microbiome
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865421000995

Internet

http://www.sciencedirect.com/science/article/pii/S2451865421000995

Similar Items